Haemonetics Co. (NYSE:HAE) Shares Sold by Schwartz Investment Counsel Inc.

Schwartz Investment Counsel Inc. trimmed its position in Haemonetics Co. (NYSE:HAE – Free Report) by 13.6% in the first quarter, Holdings Channel reports. The firm owned 159,000 shares of the medical instruments supplier’s stock after selling 25,000 shares during the quarter. Schwartz Investment Counsel Inc.’s holdings in Haemonetics were worth $13,157,000 as of its most […]

Related Keywords

New York ,United States ,Anila Lingamneni ,Josep Llorens ,Zurcher Kantonalbank Zurich Cantonalbank ,Securities Exchange Commission ,York Life Investment Management ,Haemonetics Co ,Haemonetics Corporation ,Barrington Research ,Eagle Asset Management Inc ,Holdings Channel ,Schwartz Investment Counsel Inc ,Truist Financial Corp ,Clarivest Asset Management ,Schwartz Investment Counsel ,Free Report ,Investment Counsel ,Vest Asset Management ,Asset Management ,Kantonalbank Zurich Cantonalbank ,Exchange Commission ,Get Free Report ,Visit Holdingschannel ,Haemonetics Daily ,Haemonetics ,Nyse Hae ,Hae ,Medical ,40502410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,